Works matching AU Gray, Jhanelle


Results: 49
    1
    2
    3
    4
    5

    STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 3, p. 274, doi. 10.1016/j.cllc.2023.12.010
    By:
    • Rodriguez-Abreu, Delvys;
    • Bosch-Barrera, Joaquim;
    • Gray, Jhanelle E.;
    • Myung-Ju Ahn;
    • Johnson, Melissa;
    • Xinwei Yu;
    • Mohammad, Saad;
    • Xueying Chen;
    • Todd, Trever;
    • Jongseok Kim;
    • Reck, Martin
    Publication type:
    Article
    6
    7
    8
    9

    Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.

    Published in:
    OncoTargets & Therapy, 2017, v. 10, p. 4239, doi. 10.2147/OTT.S136992
    By:
    • Creelan, Ben C.;
    • Gabrilovich, Dmitry I.;
    • Gray, Jhanelle E.;
    • Williams, Charles C.;
    • Tanvetyanon, Tawee;
    • Haura, Eric B.;
    • Weber, Jeffrey S.;
    • Gibney, Geoffrey T.;
    • Markowitz, Joseph;
    • Proksch, Joel W.;
    • Reisman, Scott A.;
    • McKee, Mark D.;
    • Chin, Melanie P.;
    • Meyer, Colin J.;
    • Antonia, Scott J.
    Publication type:
    Article
    10

    Propelling Immunotherapy Combinations Into the Clinic.

    Published in:
    Oncology (08909091), 2015, v. 29, n. 12, p. 990
    By:
    • Tchekmedyian, Nishan;
    • Gray, Jhanelle E.;
    • Creelan, Benjamin C.;
    • Chiappori, Alberto A.;
    • Beg, Amer A.;
    • Soliman, Hatem;
    • Perez, Bradford A.;
    • Antonia, Scott J.
    Publication type:
    Article
    11

    Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 517, doi. 10.1007/s00262-018-2287-9
    By:
    • Chiappori, Alberto A.;
    • Williams, Charles C.;
    • Gray, Jhanelle E.;
    • Tanvetyanon, Tawee;
    • Haura, Eric B.;
    • Creelan, Ben C.;
    • Thapa, Ram;
    • Chen, Dung-Tsa;
    • Simon, George R.;
    • Bepler, Gerold;
    • Gabrilovich, Dmitry I.;
    • Antonia, Scott J.
    Publication type:
    Article
    12

    A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1853, doi. 10.1007/s00262-018-2236-7
    By:
    • Gray, Jhanelle E.;
    • Chiappori, Alberto;
    • Williams, Charlie C.;
    • Tanvetyanon, Tawee;
    • Haura, Eric B.;
    • Creelan, Ben C.;
    • Kim, Jongphil;
    • Boyle, Theresa A.;
    • Pinder-Schenck, Mary;
    • Khalil, Farah;
    • Altiok, Soner;
    • Devane, Rebecca;
    • Noyes, David;
    • Mediavilla-Varela, Melanie;
    • Smilee, Renee;
    • Hopewell, Emily L.;
    • Kelley, Linda;
    • Antonia, Scott J.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Replicative Instability Drives Cancer Progression.

    Published in:
    Biomolecules (2218-273X), 2022, v. 12, n. 11, p. 1570, doi. 10.3390/biom12111570
    By:
    • Morris, Benjamin B.;
    • Smith, Jason P.;
    • Zhang, Qi;
    • Jiang, Zhijie;
    • Hampton, Oliver A.;
    • Churchman, Michelle L.;
    • Arnold, Susanne M.;
    • Owen, Dwight H.;
    • Gray, Jhanelle E.;
    • Dillon, Patrick M.;
    • Soliman, Hatem H.;
    • Stover, Daniel G.;
    • Colman, Howard;
    • Chakravarti, Arnab;
    • Shain, Kenneth H.;
    • Silva, Ariosto S.;
    • Villano, John L.;
    • Vogelbaum, Michael A.;
    • Borges, Virginia F.;
    • Akerley, Wallace L.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild‐Type Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2019, v. 24, n. 8, p. 1095, doi. 10.1634/theoncologist.2018-0695
    By:
    • Sequist, Lecia V.;
    • Gray, Jhanelle Elaine;
    • Harb, Wael A.;
    • Lopez‐Chavez, Ariel;
    • Doebele, Robert C.;
    • Modiano, Manuel R.;
    • Jackman, David Michael;
    • Baggstrom, Maria Quintos;
    • Atmaca, Akin;
    • Felip, Enriqueta;
    • Provencio, Mariano;
    • Cobo, Manuel;
    • Adiwijaya, Bambang;
    • Kuesters, Geoffrey;
    • Kamoun, Walid S.;
    • Andreas, Karen;
    • Pipas, J. Marc;
    • Santillana, Sergio;
    • Cho, Byoung Chul;
    • Park, Keunchil
    Publication type:
    Article
    32

    A community‐based lung cancer rapid tissue donation protocol provides high‐quality drug‐resistant specimens for proteogenomic analyses.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 1, p. 225, doi. 10.1002/cam4.2670
    By:
    • Boyle, Theresa A.;
    • Quinn, Gwendolyn P.;
    • Schabath, Matthew B.;
    • Muñoz‐Antonia, Teresita;
    • Saller, James J.;
    • Duarte, Luisa F.;
    • Hair, Laura S.;
    • Teer, Jamie K.;
    • Chiang, Derek Y.;
    • Leary, Rebecca;
    • Wong, Connie C.;
    • Savchenko, Alexander;
    • Singh, Angad P.;
    • Charette, LaSalette;
    • Mendell, Kate;
    • Gorgun, Gullu;
    • Antonia, Scott J.;
    • Chiappori, Alberto A.;
    • Creelan, Benjamin C.;
    • Gray, Jhanelle E.
    Publication type:
    Article
    33
    34

    A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer.

    Published in:
    Cancer Management & Research, 2019, v. 11, p. 9469, doi. 10.2147/CMAR.S218635
    By:
    • Schabath, Matthew B;
    • Dalvi, Tapashi B;
    • Dai, Hongyue A;
    • Crim, Alan L;
    • Midha, Anita;
    • Shire, Norah;
    • Gimbrone, Nicholas T;
    • Walker, Jill;
    • Greenawalt, Danielle M;
    • Lawrence, David;
    • Rigas, James R;
    • Brody, Robert;
    • Potter, Danielle;
    • Kumar, Naveen S;
    • Huntsman, Shane A;
    • Gray, Jhanelle E
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin.

    Published in:
    Investigational New Drugs, 2015, v. 33, n. 6, p. 1187, doi. 10.1007/s10637-015-0278-7
    By:
    • Gray, Jhanelle;
    • Infante, Jeffrey;
    • Brail, Les;
    • Simon, George;
    • Cooksey, Jennifer;
    • Jones, Suzanne;
    • Farrington, Daphne;
    • Yeo, Adeline;
    • Jackson, Kimberley;
    • Chow, Kay;
    • Zamek-Gliszczynski, Maciej;
    • Burris, Howard
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49